Carson Wealth (CWM LLC)’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.2K Buy
6,562
+5,879
+861% +$54.6K ﹤0.01% 3945
2025
Q4
$8K Sell
683
-18
-3% -$294 ﹤0.01% 4656
2025
Q3
$14K Buy
701
+41
+6% +$650 ﹤0.01% 4320
2025
Q2
$9K Sell
660
-25
-4% -$273 ﹤0.01% 4364
2025
Q1
$6K Buy
685
+4
+0.6% +$24 ﹤0.01% 4390
2024
Q4
$3K Buy
681
+667
+4,764% +$3.73K ﹤0.01% 4436
2024
Q3
$0 Buy
14
+9
+180% +$80 ﹤0.01% 5053
2024
Q2
$0 Buy
+5
New +$55 ﹤0.01% 4840
2023
Q1
Sell
-68
Closed -$1K 4268
2022
Q4
$1K Sell
68
-2
-3% -$35 ﹤0.01% 3802
2022
Q3
$1K Sell
70
-255
-78% -$5.04K ﹤0.01% 3717
2022
Q2
$9K Buy
325
+312
+2,400% +$9.24K ﹤0.01% 2653
2022
Q1
$0 Buy
13
+5
+63% +$221 ﹤0.01% 3770
2021
Q4
$0 Buy
+8
New +$606 ﹤0.01% 3607

Other funds holding OPRX

Carson Wealth (CWM LLC)'s OPRX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its OptimizeRx (OPRX) stake by 861% in Q1 2026, buying an estimated $54.6K and bringing the position to 6,562 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3945.

Carson Wealth (CWM LLC) first reported a position in OPRX in Q4 2021 and has held it in 13 quarters since. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 6,562 shares of OptimizeRx worth $41.2K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 5,879 OptimizeRx shares in Q1 2026, an estimated $54.6K.
  • OptimizeRx made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3945 holding.
  • Carson Wealth (CWM LLC) first reported a position in OptimizeRx in Q4 2021 and has held it in 13 quarters since.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.